Back to Search
Start Over
Informed consent and a risk-based approach to oncologic surgery in a cancer center during the COVID-19 pandemic.
- Source :
-
Journal of surgical oncology [J Surg Oncol] 2021 May; Vol. 123 (8), pp. 1659-1668. Date of Electronic Publication: 2021 Mar 08. - Publication Year :
- 2021
-
Abstract
- Background: Cancer patients configure a risk group for complications or death by COVID-19. For many of them, postponing or replacing their surgical treatments is not recommended. During this pandemic, surgeons must discuss the risks and benefits of treatment, and patients should sign a specific comprehensive Informed consent (IC).<br />Objectives: To report an IC and an algorithm developed for oncologic surgery during the COVID-19 outbreak.<br />Methods: We developed an IC and a process flowchart containing a preoperative symptoms questionnaire and a PCR SARS-CoV-2 test and described all perioperative steps of this program.<br />Results: Patients with negative questionnaires and tests go to surgery, those with positive ones must wait 21 days and undergo a second test before surgery is scheduled. The IC focused both on risks and benefits inherent each surgery and on the risks of perioperative SARS-CoV-2 infections or related complications. Also, the IC discusses the possibility of sudden replacement of medical staff member(s) due to the pandemic; the possibility of unexpected complications demanding emergency procedures that cannot be specifically discussed in advance is addressed.<br />Conclusions: During the pandemic, specific tools must be developed to ensure safe experiences for surgical patients and prevent them from having misunderstandings concerning their care.<br /> (© 2021 Wiley Periodicals LLC.)
Details
- Language :
- English
- ISSN :
- 1096-9098
- Volume :
- 123
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Journal of surgical oncology
- Publication Type :
- Academic Journal
- Accession number :
- 33684245
- Full Text :
- https://doi.org/10.1002/jso.26452